Table 1.
Drug name | Indication | Drug class | Risk* |
---|---|---|---|
Procainamide | Arrhythmias | Anti-arrhythmic | High |
Hydralazine | Hypertension | Vasodilator | High |
Quinidine | Drug for acute malaria and to treat arrhythmias | Anti-arrhythmic | Moderate |
Isoniazid | Anti-tuberculosis drug | Hydrazide | Low |
Minocycline | Bacterial infection; primarily used to treat acne | Antibacterials for systemic use; tetracycline | Low |
Carbamazepine | Epilepsy | Anti-convulsant; carboxamide derivative | Low |
Acebutolol | Hypertension, angina and arrhythmias | Antihypertensive; beta-adrenoreceptor blocker | Low |
Captopril | Hypertension | Antihypertensive; angiotensin-converting enzyme (ACE) inhibitor | Low |
Methyldopa | Hypertension | Antihypertensive; centrally acting anti-adrenergic agent | Low |
Chlorpromazine | Schizophrenia and other psychoses | Psycholeptic; antipsychotic | Low |
Prophylthiouracil | Hyperthyroidism | Systemic hormonal preparations; thyroid therapy | Low |
Due to a lack of analytical studies, risks are currently assigned based on number of case reports published in the literature [3].